Recurrence of keratoconus characteristics: A clinical and histologic follow-up analysis of donor grafts

Ophthalmology

Volumn 110, Issue 10, 2003, Pages 1920-1925

  Bourges, Jean Louis ^a   Savoldelli, Michèle ^a   Dighiero, Paul ^e   Assouline, Michael ^b   Pouliquen, Yves ^a   BenEzra, David ^c   Renard, Gilles ^a   Behar Cohen, Francine ^b,d  

^a HÔTEL DIEU   (France)

^b FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d INSERM   (France)

^e INSERM U450 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; ASTIGMATISM; BOWMAN MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA THICKNESS; CORNEA TRANSPLANTATION; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GRAFT FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSTRUMENT; KERATOCONUS; KERATOMETRY; KERATOSCOPY; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT INDICATION;

EID: 0141513663     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00617-1     Document Type: Article

References (31)

1. Pouliquen Y. Doyne lecture keratoconus. Eye 1987;1:1-14.
2. Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans-a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 1990;228:517-23.
3. Fullwood NJ, Meek KM, Malik NS, Tuft SJ. A comparison of proteoglycan arrangement in normal and keratoconus human corneas. Biochem Soc Trans 1990;18:961-2.
4. Sawaguchi S, Yue BY, Chang I, et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991;32: 1846-53.
5. Funderburgh JL, Funderburgh ML, Rodrigues MM, et al. Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases. Invest Ophthalmol Vis Sci 1990;31:419-28.
6. Bureau J, Fabre EJ, Hecquet C, et al. Modification of prostaglandin E2 and collagen synthesis in keratoconus fibroblasts, associated with an increase of interleukin 1 alpha receptor number. C R Acad Sci III 1993;316:425-30.
7. Sawaguchi S, Twining SS, Yue BY, et al. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res 1990;50: 549-54.
8. Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res 1992;11:849-62.
9. Brown D, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res 1993;12:571-81.
10. Scroggs MW, Proia AD. Histopathological variation in keratoconus. Cornea 1992;11:553-9.
11. Kaas-Hansen M. The histopathological changes of keratoconus. Acta Ophthalmol (Copenh) 1993;71:411-4.
12. Pouliquen Y, Renard G, Savoldelli M. Keratoconus associated with Terrien's marginal degeneration. A clinical and ultrastructural study. Acta Ophthalmol Suppl 1989;192:174-81.
13. Hoang-Xuan T, Elmaleh C, Dhermy P, et al. Association d'une dystrophie grillagée et d'un kératocône: étude anatomoclinique à propos d'un cas [Association of a lattice dystrophy and keratoconus: anatomo-clinical study apropos of a case]. Bull Soc Ophtalmol Fr 1989;89:35-8.
14. Kirkness CM, Ficker LA, Steele AD, Rice NS. Refractive surgery for graft-induced astigmatism after penetrating keratoplasty for keratoconus. Ophthalmology 1991;98:1786-92.
15. Price FW Jr, Whitson WE, Marks RG. Progression of visual acuity after penetrating keratoplasty. Ophthalmology 1991;98: 1177-85.
16. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal topography in family members of patients with keratoconus. Arch Ophthalmol 1990;108:365-71.
17. Gonzalez V, McDonnell PJ. Computer-assisted corneal topography in parents of patients with keratoconus. Arch Ophthalmol 1992;110:1413-4.
18. Fabre EJ, Bureau J, Pouliquen Y, Lorans G. Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res 1991;10:585-92.
19. Karseras AG, Ruben M. Aetiology of keratoconus. Br J Ophthalmol 1976;60:522-5.
20. Kahan IL, Varsanyi-Nagy M, Toth M, Nadrai A. The possible role of tear fluid thyroxine in keratoconus development. Exp Eye Res 1990;50:339-43.
21. Lindberg K, Brown ME, Chaves HV, et al. In vitro propagation of human ocular surface epithelial cells for transplantation. Invest Ophthalmol Vis Sci 1993;34:2672-9.
22. Maguire LJ, Lowry JC. Identifying progression of subclinical keratoconus by serial topography analysis. Am J Ophthalmol 1991;112:41-5.
23. Bechrakis N, Blom ML, Stark WJ, Green WR. Recurrent keratoconus. Cornea 1994;13:73-7.
24. Kirkness CM, Ficker LA, Steele AD, Rice NS. The success of penetrating keratoplasty for keratoconus. Eye 1990;4:673-88.
25. Khong AM, Mannis MJ, Plotnik RD, Johnson CA. Computerized topographic analysis of the healing graft after penetrating keratoplasty for keratoconus. Am J Ophthalmol 1993;115: 209-15.
26. Abelson MB, Collin HB, Gillette TE, Dohlman CH. Recurrent keratoconus after keratoplasty. Am J Ophthalmol 1980;90: 672-6.
27. Nirankari VS, Karesh J, Bastion F, et al. Recurrence of keratoconus in donor cornea 22 years after successful keratoplasty. Br J Ophthalmol 1983;67:23-8.
28. Rubinfeld RS, Traboulsi EI, Arentsen JJ, Eagle RC Jr. Keratoconus after penetrating keratoplasty. Ophthalmic Surg 1990; 21:420-2.
29. Eiferman RA. Recurrence of keratoconus [letter]. Br J Ophthalmol 1984;68:289-90.
30. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986; 101:267-73.
31. Pearson AR, Soneji B, Sarvananthan N, Sandford-Smith JH. Does ethnic origin influence the incidence or severity of keratoconus? Eye 2000;14:625-8.